$8.25M Natera Settlement Ends Class Action Lawsuit Over Allegedly Inaccurate Prenatal Testing

New to ClassAction.org? Read our Newswire Disclaimer

Natera has agreed to an $8,250,000 settlement to resolve a class action lawsuit that claimed the genetic testing company manufactured and sold unreliable prenatal tests and misrepresented the products’ accuracy to consumers.

Get class action lawsuit and class action settlement news sent to your inbox – sign up for ClassAction.org’s free weekly newsletter.

The Natera prenatal testing class action settlement received preliminary approval from the court on November 8, 2025 and covers all individuals in the United States who paid out of pocket, including a co-pay, co-insurance or deductible, for a Natera noninvasive prenatal test (NIPT), sold under the Panorama or Vasistera brands, in the following states and between the following dates:

• Ohio—February 17, 2016 through August 7, 2025;
• New Jersey—May 5, 2016 through August 7, 2025;
• Florida—February 24, 2017 through August 7, 2025;
• New York and Illinois—April 27, 2017 through August 7, 2025; and
• All other states—February 17, 2018 through August 7, 2025.

The court-approved website for the Natera settlement can be found at NateraNIPTSettlement.com/.

The class action settlement does not cover consumers whose Natera prenatal screening tests were paid for entirely by insurance or another third-party source.

According to the website, Natera settlement class members who submit a valid, timely claim form have multiple options for reimbursement. All Natera class members with a valid, timely claim form are eligible to receive a one-time cash payment of $30 with no proof of purchase required. This payment, the agreement stipulates, may become pro-rated depending on the total number of valid claims filed for all settlement benefits and how much remains in the net settlement fund after the payment of the cost of attorneys’ fees, lead plaintiff service awards and settlement administration costs.

Related Reading: Healthcare Website Data Privacy Investigations: Was Your Info Shared?

The settlement site notes that Natera class members who submit with their claim form documented proof of purchase of a Natera NIPT are eligible to receive a one-time cash payment of up to 10 percent of the total cost of purchase if the out-of-pocket costs were greater than $300. This payment may also become prorated, the agreement adds.

Class members may elect to receive their Natera payout via check or electronic payment, the website relays.

As part of the class action settlement, Natera has also agreed to add an italicized disclosure on its website to inform consumers that prenatal tests cannot determine with certainty the genetic conditions of a fetus, and that high-risk results need diagnostic confirmation from a healthcare provider.

To submit a Natera prenatal testing settlement claim form online, class members can head to this page and enter the unique ID and PIN as provided on their received copy of the settlement notice. Alternatively, class members may download a PDF of the claim form from the class action settlement website to print, fill out and return by mail to the address of the settlement administrator listed on the second page of the document.

Consumers who believe they may be a Natera settlement class members but did not receive notice should contact the settlement administrator to confirm their identity and obtain their login information.

All Natera settlement claim forms must be submitted online or by mail by March 23, 2026.

The court will determine whether to grant final approval to the Natera settlement at a hearing on April 23, 2026. Compensation will begin to be distributed to class members only after final approval is granted and any appeals are resolved.

The Natera class action lawsuit alleged that the women’s genetic testing company produced and sold prenatal tests that it knew—or was reckless in not knowing—could not reliably assess whether a fetus has certain genetic disorders and failed to give consumers proper notice that its NIPTs were allegedly susceptible to false, inconsistent results.

Check out ClassAction.org’s lawsuit list for the latest open class action lawsuits and investigations.